Text Messaging Between Patients With Inflammatory Rheumatic Diseases and Pharmacists to Solve Drug-Related Problems: Prospective Feasibility Study
Open Access
- 8 October 2025
- journal article
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e66514
Abstract
Background: Patients with inflammatory rheumatic diseases often experience drug-related problems (DRPs). As these can result in negative health consequences, DRPs should be identified and addressed in a timely manner. Text messaging between patients and pharmacists at the initiative of the patient has the potential to deliver support with DRPs more continuously, increase accessibility and efficiency, and enhance patient involvement in the process of identifying and solving DRPs. Objective: This study aimed to assess the feasibility of text messaging from both the patients’ and health care practitioners’ perspectives before a large-scale implementation. Methods: Adult patients using a disease-modifying antirheumatic drug were given access to text messaging with pharmacists to discuss DRPs for a period of 8 weeks. Patients received a response from a pharmacist within 4 working hours. Feasibility was evaluated based on five domains of Bowen’s framework for designing feasibility studies: (1) demand: actual use, expressed interest (user version of the Mobile Application Rating Scale – section E), and factors impacting future use; (2) limited efficacy: number of DRPs solved, DRPs resulting in follow-up, and DRPs warranting involvement of health care provider; (3) implementation: degree of execution (number of conversations answered within service level) and resources needed (pharmacists’ time investment per conversation); (4) acceptability: satisfaction and appropriateness (theoretical framework of acceptability); and (5) practicality: ability to carry out intervention activities (System Usability Scale). Data were collected by means of usage data and a questionnaire. Results: In total, 45 patients (median age 57, IQR 52-65 y; n=31, 69% female) and 5 pharmacists (median age 41, IQR 26-47 y; n=1, 20% female) actively participated in this study. In the demand domain, 158 unique DRPs were raised in 133 conversations, with a median of 3 (IQR 2-4) unique DRPs per patient. Expressed interest was rated high by patients (median 4, IQR 4-5), and 90% (37/41) of patients would recommend text messaging to others. In the limited-efficacy domain, all DRPs were solved, and 77% (122/158) of DRPs warranted involvement of a health care provider. In the implementation domain, 87% (116/133) of conversations were answered within the promised timeframe with a median time investment of 4:15 (IQR 2:21-7:27) minutes per conversation. Acceptability was rated high by patients (median 4, IQR 4-5) and pharmacists (median 5, IQR 4-5). Finally, in the practicality domain, System Usability Scale was scored above average for patients (mean 72, SD 18) and pharmacists (mean 81, SD 16). Conclusion: Text messaging with pharmacists at the initiative of patients with rheumatic diseases seems feasible for discussing DRPs in terms of limited efficacy, implementation, acceptability, demand, and practicality for patients and pharmacists.Keywords
This publication has 29 references indexed in Scilit:
- Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in DermatologyJournal of Medical Internet Research, 2017
- Development and Validation of the User Version of the Mobile Application Rating Scale (uMARS)JMIR mHealth and uHealth, 2016
- Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation studyTrials, 2014
- A Comparison of In-person, Telephone, and Secure Messaging for Type 2 Diabetes Self-Management SupportThe Diabetes Educator, 2014
- Direct health care costs of hospital admissions due to adverse events in the NetherlandsEuropean Journal of Public Health, 2014
- The contribution of patient interviews to the identification of drug-related problems in home medication reviewJournal of Clinical Pharmacy and Therapeutics, 2012
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM studyValue in Health, 2011
- How We Design Feasibility StudiesAmerican Journal of Preventive Medicine, 2009
- Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practiceQJM: An International Journal of Medicine, 2001